Development
Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 365.00M | 4.61B | 3.11B | 13.03B | 14.52B |
| Total Depreciation and Amortization | 3.73B | 3.70B | 3.66B | 3.67B | 3.79B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.11B | 11.58B | 12.92B | 3.35B | 3.57B |
| Change in Net Operating Assets | -2.21B | -2.70B | -4.61B | -4.37B | -2.78B |
| Cash from Operations | 13.01B | 17.19B | 15.08B | 15.67B | 19.10B |
| Capital Expenditure | -3.86B | -4.02B | -4.25B | -4.41B | -4.39B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -12.03B | -12.03B | -12.15B | -1.45B | -121.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.81B | 171.00M | -112.00M | -287.00M | -451.00M |
| Cash from Investing | -14.08B | -15.88B | -16.51B | -6.15B | -4.96B |
| Total Debt Issued | 5.94B | 5.94B | 7.88B | -- | -- |
| Total Debt Repaid | -1.76B | -1.75B | -2.75B | -1.00B | -2.25B |
| Issuance of Common Stock | 125.00M | 384.00M | 387.00M | 402.00M | 384.00M |
| Repurchase of Common Stock | -1.35B | -953.00M | -487.00M | -149.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.45B | -7.34B | -7.24B | -7.12B | -7.01B |
| Other Financing Activities | -328.00M | -393.00M | -348.00M | -218.00M | -240.00M |
| Cash from Financing | -4.81B | -4.12B | -2.55B | -8.09B | -9.12B |
| Foreign Exchange rate Adjustments | 23.00M | 203.00M | -52.00M | -268.00M | -410.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.86B | -2.61B | -4.04B | 1.17B | 4.61B |